90 related articles for article (PubMed ID: 2824359)
1. Identification of Na+,K+-ATPase inhibitors of volume-expanded hog plasma.
Inagami T; Tamura M
Hypertension; 1987 Nov; 10(5 Pt 2):I108-12. PubMed ID: 2824359
[TBL] [Abstract][Full Text] [Related]
2. Lysophosphatidylcholines containing polyunsaturated fatty acids were found as Na+, K+-ATPase inhibitors in acutely volume-expanded hog.
Tamura M; Harris TM; Higashimori K; Sweetman BJ; Blair IA; Inagami T
Biochemistry; 1987 May; 26(10):2797-806. PubMed ID: 3038164
[TBL] [Abstract][Full Text] [Related]
3. A search for endogenous Na+,K+-ATPase inhibitor in acutely volume-expanded hog plasma led to lysophosphatidylcholine gamma-stearoyl.
Tamura M; Inagami T; Kinoshita T; Kuwano H
J Hypertens; 1987 Apr; 5(2):219-25. PubMed ID: 2886540
[TBL] [Abstract][Full Text] [Related]
4. Identification of linoleic and oleic acids as endogenous Na+,K+-ATPase inhibitors from acute volume-expanded hog plasma.
Tamura M; Kuwano H; Kinoshita T; Inagami T
J Biol Chem; 1985 Aug; 260(17):9672-7. PubMed ID: 2991258
[TBL] [Abstract][Full Text] [Related]
5. Isolation and characterization of an endogenous Na+,K(+)-ATPase-specific inhibitor from pig urine.
Tamura M; Harris TM; Konishi F; Inagami T
Eur J Biochem; 1993 Jan; 211(1-2):317-27. PubMed ID: 8381085
[TBL] [Abstract][Full Text] [Related]
6. Isolation and characterization of a specific endogenous Na+,K+-ATPase inhibitor from bovine adrenal.
Tamura M; Lam TT; Inagami T
Biochemistry; 1988 Jun; 27(12):4244-53. PubMed ID: 2844224
[TBL] [Abstract][Full Text] [Related]
7. Identification of Na+/K+-ATPase inhibitors in bovine plasma as fatty acids and hydrocarbons.
Tal DM; Yanuck MD; van Hall G; Karlish SJ
Biochim Biophys Acta; 1989 Oct; 985(1):55-9. PubMed ID: 2551389
[TBL] [Abstract][Full Text] [Related]
8. A novel endogenous sodium-pump inhibitor in pig urine: purification and comparison with the inhibitor purified from bovine adrenal glands.
Tamura M; Konishi F; Inagami T
J Cardiovasc Pharmacol; 1993; 22 Suppl 2():S47-50. PubMed ID: 7508027
[TBL] [Abstract][Full Text] [Related]
9. Characteristics of a (Na+-K+)-ATPase inhibitor in extracts of tea.
Sagnella GA; MacGregor GA
Am J Clin Nutr; 1984 Jul; 40(1):36-41. PubMed ID: 6331148
[TBL] [Abstract][Full Text] [Related]
10. Isolation and identification of hemin as an endogenous Na+/K(+)-ATPase inhibitor from porcine blood cells.
Yasuhara T; Mori M; Wakamatsu K; Kubo K
Biochem Biophys Res Commun; 1991 Jul; 178(1):95-103. PubMed ID: 1648917
[TBL] [Abstract][Full Text] [Related]
11. Inhibition of Na,K-ATPase and sodium pump by protein kinase C regulators sphingosine, lysophosphatidylcholine, and oleic acid.
Oishi K; Zheng B; Kuo JF
J Biol Chem; 1990 Jan; 265(1):70-5. PubMed ID: 2152929
[TBL] [Abstract][Full Text] [Related]
12. Purification of a Na+/K+ ATPase inhibitor from borderline hypertensives' plasma.
Boschi S; Borghi C; Munarini A; Costa FV; Lu ZR; deVries D; Ambrosioni E
Biochem Biophys Res Commun; 1990 Jun; 169(2):360-8. PubMed ID: 2162662
[TBL] [Abstract][Full Text] [Related]
13. Binding of unsaturated fatty acids to Na+, K(+)-ATPase leading to inhibition and inactivation.
Swarts HG; Schuurmans Stekhoven FM; De Pont JJ
Biochim Biophys Acta; 1990 May; 1024(1):32-40. PubMed ID: 2159804
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of protein kinase C, (sodium plus potassium)-activated adenosine triphosphatase, and sodium pump by synthetic phospholipid analogues.
Zheng B; Oishi K; Shoji M; Eibl H; Berdel WE; Hajdu J; Vogler WR; Kuo JF
Cancer Res; 1990 May; 50(10):3025-31. PubMed ID: 2159369
[TBL] [Abstract][Full Text] [Related]
15. A role for the sodium, potassium adenosine triphosphatase (Na+,K+ ATPase) enzyme in degranulation of rat basophilic leukaemia cells.
Gentile DA; Skoner DP
Clin Exp Allergy; 1996 Dec; 26(12):1449-60. PubMed ID: 9027446
[TBL] [Abstract][Full Text] [Related]
16. Partial purification and properties of the inhibitors of Na, K-ATPase and ouabain-binding in bovine central nervous system.
Akagawa K; Hara N; Tsukada Y
J Neurochem; 1984 Mar; 42(3):775-80. PubMed ID: 6319608
[TBL] [Abstract][Full Text] [Related]
17. Higher plasma Na+,K+-ATPase inhibitory activity in essential hypertensive patients.
Vasdev S; Fernandez PG; Longerich L; Gault H
Can J Cardiol; 1989; 5(5):249-54. PubMed ID: 2547501
[TBL] [Abstract][Full Text] [Related]
18. Isolation of an endogenous Na-pump specific inhibitor from normal pig urine: characterization and comparison with the inhibitor purified from bovine adrenal glands.
Tamura M; Naruse M; Sakakibara M; Inagami T
Biochim Biophys Acta; 1993 May; 1157(1):15-22. PubMed ID: 8388731
[TBL] [Abstract][Full Text] [Related]
19. Identification of 11,13-dihydroxy-14-octadecaenoic acid as a circulating Na+/K(+)-ATPase inhibitor.
Lichtstein D; Samuelov S; Gati I; Felix AM; Gabriel TF; Deutsch J
J Endocrinol; 1991 Jan; 128(1):71-8. PubMed ID: 1847965
[TBL] [Abstract][Full Text] [Related]
20. Affinity chromatography for human Na+, K+-ATPase inhibitors in plasma and urine.
Henning G; Cloix JF; Wainer IW; Pernollet MG; Devynck MA; Meyer P
Life Sci; 1985 May; 36(18):1787-98. PubMed ID: 2984510
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
